Clinical Trial

A Phase III Trial of HRS-1893 in Patients With Obstructive Hypertrophic Cardiomyopathy

Name: A Phase III Trial of HRS-1893 in Patients With Obstructive Hypertrophic Cardiomyopathy — clinical trial record (NCT07021976)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

The study is being conducted to evaluate the efficacy and safety of HRS-1893 for obstructive hypertrophic cardiomyopathy.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-06-06.

Status change: Not Yet Recruiting → Recruiting 2025-08-19

Trial Details

NCT Number	NCT07021976
Lead Sponsor	Shandong Suncadia Medicine Co., Ltd.
Conditions	Obstructive Hypertrophic Cardiomyopathy
Enrollment	216 participants
Start Date	2025-08-11
Primary Completion	2026-09 (estimated)
Study Completion	2026-11 (estimated)
Updated on ClinicalTrials.gov	2025-08-20